NFX1 plays a role in human papillomavirus type 16 E6 activation of NFκB activity

Journal of Virology

Volumn 84, Issue 21, 2010, Pages 11461-11469

  Xu, Mei ^a,b   Katzenellenbogen, Rachel A ^a,c,d   Grandori, Carla ^a,c   Galloway, Denise A ^a  

^a Fred Hutchinson Cancer Research Center   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

^c UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^d SEATTLE CHILDREN S RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PROTEIN E6; PROTEIN P105; SHORT HAIRPIN RNA; TELOMERASE REVERSE TRANSCRIPTASE; VIRUS DNA; X BOX BINDING PROTEIN 1; E6 PROTEIN, HUMAN PAPILLOMAVIRUS TYPE 16; NFKB1 PROTEIN, HUMAN; NFX1 PROTEIN, HUMAN; ONCOPROTEIN; REPRESSOR PROTEIN; TRANSCRIPTION FACTOR;

APOPTOSIS; ARTICLE; CELL STRAIN HCT116; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; DOWN REGULATION; ENZYME ACTIVITY; EPITHELIUM CELL; GENE EXPRESSION; HELA CELL; HUMAN; HUMAN CELL; HUMAN PAPILLOMAVIRUS TYPE 16; KERATINOCYTE; MICROARRAY ANALYSIS; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN DEGRADATION; PROTEIN EXPRESSION; REGULATORY SEQUENCE; SIGNAL TRANSDUCTION; UPREGULATION; VIRUS ACTIVATION; VIRUS CELL INTERACTION; VIRUS REPLICATION; CELL CULTURE; GENETICS; METABOLISM; PHYSIOLOGY; TRANSCRIPTION INITIATION;

HUMAN PAPILLOMAVIRUS; HUMAN PAPILLOMAVIRUS TYPE 16;

CELLS, CULTURED; HUMANS; KERATINOCYTES; MICROARRAY ANALYSIS; NF-KAPPA B; NF-KAPPA B P50 SUBUNIT; ONCOGENE PROTEINS, VIRAL; PROMOTER REGIONS, GENETIC; REPRESSOR PROTEINS; TRANSCRIPTION FACTORS; TRANSCRIPTIONAL ACTIVATION;

EID: 77957951309     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.00538-10     Document Type: Article

References (74)

1. Aasland, R., T. J. Gibson, and A. F. Stewart. 1995. The PHD finger: implications for chromatin-mediated transcriptional regulation. Trends Biochem. Sci. 20:56-59.
2. An, J., D. Mo, H. Liu, M. S. Veena, E. S. Srivatsan, R. Massoumi, and M. B. Rettig. 2008. Inactivation of the CYLD deubiquitinase by HPV E6 mediates hypoxia-induced NF-kappaB activation. Cancer Cell 14:394-407.
3. Babu, G. R., W. Jin, L. Norman, M. Waterfield, M. Chang, X. Wu, M. Zhang, and S. C. Sun. 2006. Phosphorylation of NF-kappaB1/p105 by oncoprotein kinase Tpl2: implications for a novel mechanism of Tpl2 regulation. Biochim. Biophys. Acta 1763:174-181.
4. Beinke, S., and S. C. Ley. 2004. Functions of NF-kappaB1 and NF-kappaB2 in immune cell biology. Biochem. J. 382:393-409.
5. Bosch, F. X., M. M. Manos, N. Munoz, M. Sherman, A. M. Jansen, J. Peto, M. H. Schiffman, V. Moreno, R. Kurman, and K. V. Shah. 1995. Prevalence of human papillomavirus in cervical cancer: a worldwide perspective. International biological study on cervical cancer (IBSCC) Study Group. J. Natl. Cancer Inst. 87:796-802.
6. Branca, M., C. Giorgi, M. Ciotti, D. Santini, L. Di Bonito, S. Costa, A. Benedetto, D. Bonifacio, P. Di Bonito, P. Paba, L. Accardi, L. Mariani, M. Ruutu, S. Syrjanen, C. Favalli, and K. Syrjanen. 2006. Upregulation of nuclear factor-kappaB (NF-kappaB) is related to the grade of cervical intraepithelial neoplasia, but is not an independent predictor of high-risk human papillomavirus or disease outcome in cervical cancer. Diagn. Cytopathol. 34:555-563.
7. Chang, P. Y., K. Draheim, M. A. Kelliher, and S. Miyamoto. 2006. NFKB1 is a direct target of the TAL1 oncoprotein in human T leukemia cells. Cancer Res. 66:6008-6013.
8. Chang, P. Y., and S. Miyamoto. 2006. Nuclear factor-kappaB dimer exchange promotes a p21(waf1/cip1) superinduction response in human T leukemic cells. Mol. Cancer Res. 4:101-112.
9. Chaturvedi, V., J. Z. Qin, M. F. Denning, D. Choubey, M. O. Diaz, and B. J. Nickoloff. 1999. Apoptosis in proliferating, senescent, and immortalized keratinocytes. J. Biol. Chem. 274:23358-23367.
10. Cho, J., and P. N. Tsichlis. 2005. Phosphorylation at Thr-290 regulates Tpl2 binding to NF-kappaB1/p105 and Tpl2 activation and degradation by lipopolysaccharide. Proc. Natl. Acad. Sci. U. S. A. 102:2350-2355.
11. Cogswell, P. C., M. W. Mayo, and A. S. Baldwin, Jr. 1997. Involvement of Egr-1/RelA synergy in distinguishing T cell activation from tumor necrosis factor-alpha-induced NF-kappa B1 transcription. J. Exp. Med. 185:491-497.
12. Cogswell, P. C., R. I. Scheinman, and A. S. Baldwin, Jr. 1993. Promoter of the human NF-kappa B p50/p105 gene. Regulation by NF-kappa B subunits and by c-REL. J. Immunol. 150:2794-2804.
13. Counter, C. M., A. A. Avilion, C. E. LeFeuvre, N. G. Stewart, C. W. Greider, C. B. Harley, and S. Bacchetti. 1992. Telomere shortening associated with chromosome instability is arrested in immortal cells which express telomerase activity. EMBO J. 11:1921-1929.
14. Cude, K., Y. Wang, H. J. Choi, S. L. Hsuan, H. Zhang, C. Y. Wang, and Z. Xia. 2007. Regulation of the G2-M cell cycle progression by the ERK5-NFkappaB signaling pathway. J. Cell Biol. 177:253-264. (Pubitemid 46658637)
15. Dai, X., and L. B. Rothman-Denes. 1999. DNA structure and transcription. Curr. Opin. Microbiol. 2:126-130.
16. Dove, S. L., J. K. Joung, and A. Hochschild. 1997. Activation of prokaryotic transcription through arbitrary protein-protein contacts. Nature 386:627-630.
17. Du, J., G. G. Chen, A. C. Vlantis, H. Xu, R. K. Tsang, and A. C. van Hasselt. 2003. The nuclear localization of NFkappaB and p53 is positively correlated with HPV16 E7 level in laryngeal squamous cell carcinoma. J. Histochem Cytochem. 51:533-539. (Pubitemid 36418049)
18. Duerksen-Hughes, P. J., J. Yang, and S. B. Schwartz. 1999. HPV 16 E6 blocks TNF-mediated apoptosis in mouse fibroblast LM cells. Virology 264:55-65.
19. Dyson, N., P. M. Howley, K. Munger, and E. Harlow. 1989. The human papilloma virus-16 E7 oncoprotein is able to bind to the retinoblastoma gene product. Science 243:934-937.
20. Filippova, M., T. A. Brown-Bryan, C. A. Casiano, and P. J. Duerksen-Hughes. 2005. The human papillomavirus 16 E6 protein can either protect or further sensitize cells to TNF: effect of dose. Cell Death Differ. 12:1622-1635.
21. Filippova, M., H. Song, J. L. Connolly, T. S. Dermody, and P. J. Duerksen-Hughes. 2002. The human papillomavirus 16 E6 protein binds to tumor necrosis factor (TNF) R1 and protects cells from TNF-induced apoptosis. J. Biol. Chem. 277:21730-21739.
22. Fisher, G. J., S. C. Datta, H. S. Talwar, Z. Q. Wang, J. Varani, S. Kang, and J. J. Voorhees. 1996. Molecular basis of sun-induced premature skin ageing and retinoid antagonism. Nature 379:335-339.
23. Fontaine, V., E. van der Meijden, J. de Graaf, J. ter Schegget, and L. Struyk. 2000. A functional NF-kappaB binding site in the human papillomavirus type 16 long control region. Virology 272:40-49.
24. Gardiol, D., C. Kuhne, B. Glaunsinger, S. S. Lee, R. Javier, and L. Banks. 1999. Oncogenic human papillomavirus E6 proteins target the discs large tumour suppressor for proteasome-mediated degradation. Oncogene 18:5487-5496.
25. Gewin, L., and D. A. Galloway. 2001. E box-dependent activation of telomerase by human papillomavirus type 16 E6 does not require induction of c-myc. J. Virol. 75:7198-7201.
26. Gewin, L., H. Myers, T. Kiyono, and D. A. Galloway. 2004. Identification of a novel telomerase repressor that interacts with the human papillomavirus type-16 E6/E6-AP complex. Genes Dev. 18:2269-2282.
27. Glaunsinger, B. A., S. S. Lee, M. Thomas, L. Banks, and R. Javier. 2000. Interactions of the PDZ-protein MAGI-1 with adenovirus E4-ORF1 and high-risk papillomavirus E6 oncoproteins. Oncogene 19:5270-5280.
28. Havard, L., P. Delvenne, P. Frare, J. Boniver, and S. L. Giannini. 2002. Differential production of cytokines and activation of NF-kappaB in HPV-transformed keratinocytes. Virology 298:271-285.
29. Havard, L., S. Rahmouni, J. Boniver, and P. Delvenne. 2005. High levels of p105 (NFKB1) and p100 (NFKB2) proteins in HPV16-transformed keratinocytes: role of E6 and E7 oncoproteins. Virology 331:357-366. (Pubitemid 40075461)
30. Hayden, M. S., and S. Ghosh. 2004. Signaling to NF-kappaB. Genes Dev. 18:2195-2224.
31. Hayden, M. S., A. P. West, and S. Ghosh. 2006. NF-kappaB and the immune response. Oncogene 25:6758-6780.
32. Hayden, M. S., A. P. West, and S. Ghosh. 2006. SnapShot: NF-kappaB signaling pathways. Cell 127:1286-1287.
33. Hochschild, A., and S. L. Dove. 1998. Protein-protein contacts that activate and repress prokaryotic transcription. Cell 92:597-600.
34. Huibregtse, J. M., M. Scheffner, and P. M. Howley. 1994. E6-AP directs the HPV E6-dependent inactivation of p53 and is representative of a family of structurally and functionally related proteins. Cold Spring Harbor Symp. Quant. Biol. 59:237-245.
35. James, M. A., J. H. Lee, and A. J. Klingelhutz. 2006. Human papillomavirus type 16 E6 activates NF-kappaB, induces cIAP-2 expression, and protects against apoptosis in a PDZ binding motif-dependent manner. J. Virol. 80:5301-5307.
36. Karin, M., and F. R. Greten. 2005. NF-kappaB: linking inflammation and immunity to cancer development and progression. Nat. Rev. Immunol. 5:749-759.
37. Katzenellenbogen, R. A., E. M. Egelkrout, P. Vliet-Gregg, L. C. Gewin, P. R. Gafken, and D. A. Galloway. 2007. NFX1-123 and poly(A) binding proteins synergistically augment activation of telomerase in human papillomavirus type 16 E6-expressing cells. J. Virol. 81:3786-3796.
38. Katzenellenbogen, R. A., P. Vliet-Gregg, M. Xu, and D. A. Galloway. 2009. NFX1-123 increases hTERT expression and telomerase activity post-transcriptionally in HPV 16E6 keratinocytes. J. Virol.
39. Khavari, T. A., and J. Rinn. 2007. Ras/Erk MAPK signaling in epidermal homeostasis and neoplasia. Cell Cycle 6:2928-2931.
40. Kiyono, T., A. Hiraiwa, M. Fujita, Y. Hayashi, T. Akiyama, and M. Ishibashi. 1997. Binding of high-risk human papillomavirus E6 oncoproteins to the human homologue of the Drosophila discs large tumor suppressor protein. Proc. Natl. Acad. Sci. U. S. A. 94:11612-11616.
41. Klipper-Aurbach, Y., M. Wasserman, N. Braunspiegel-Weintrob, D. Borstein, S. Peleg, S. Assa, M. Karp, Y. Benjamini, Y. Hochberg, and Z. Laron. 1995. Mathematical formulae for the prediction of the residual beta cell function during the first two years of disease in children and adolescents with insulin-dependent diabetes mellitus. Med. Hypotheses 45:486-490.
42. Lambert, P. F., M. J. Ludford-Menting, N. J. Deacon, I. Kola, and R. R. Doherty. 1997. The nfkb1 promoter is controlled by proteins of the Ets family. Mol. Biol. Cell 8:313-323.
43. Lee, C., and L. A. Laimins. 2004. Role of the PDZ domain-binding motif of the oncoprotein E6 in the pathogenesis of human papillomavirus type 31. J. Virol. 78:12366-12377.
44. Lee, S. S., B. Glaunsinger, F. Mantovani, L. Banks, and R. T. Javier. 2000. Multi-PDZ domain protein MUPP1 is a cellular target for both adenovirus E4-ORF1 and high-risk papillomavirus type 18 E6 oncoproteins. J. Virol. 74:9680-9693.
45. Li, C., and W. H. Wong. 2001. Model-based analysis of oligonucleotide arrays: expression index computation and outlier detection. Proc. Natl. Acad. Sci. U. S. A. 98:31-36.
46. Li, Z., X. Wang, R. Y. Yu, B. B. Ding, J. J. Yu, X. M. Dai, A. Naganuma, E. R. Stanley, and B. H. Ye. 2005. BCL-6 negatively regulates expression of the NF-kappaB1 p105/p50 subunit. J. Immunol. 174:205-214.
47. Liu, X., H. Yuan, B. Fu, G. L. Disbrow, T. Apolinario, V. Tomaic, M. L. Kelley, C. C. Baker, J. Huibregtse, and R. Schlegel. 2005. The E6AP ubiquitin ligase is required for transactivation of the hTERT promoter by the human papillomavirus E6 oncoprotein. J. Biol. Chem. 280:10807-10816.
48. Mansur, C. P., and E. J. Androphy. 1993. Cellular transformation by papillomavirus oncoproteins. Biochim. Biophys. Acta 1155:323-345.
49. Mercurio, F., and A. M. Manning. 1999. Multiple signals converging on NF-kappaB. Curr. Opin. Cell Biol. 11:226-232.
50. Mishra, A., A. C. Bharti, P. Varghese, D. Saluja, and B. C. Das. 2006. Differential expression and activation of NF-kappaB family proteins during oral carcinogenesis: role of high risk human papillomavirus infection. Int. J. Cancer 119:2840-2850.
51. Münger, K., W. C. Phelps, V. Bubb, P. M. Howley, and R. Schlegel. 1989. The E6 and E7 genes of the human papillomavirus type 16 together are necessary and sufficient for transformation of primary human keratinocytes. J. Virol. 63:4417-4421. (Pubitemid 19229441)
52. Münger, K., B. A. Werness, N. Dyson, W. C. Phelps, E. Harlow, and P. M. Howley. 1989. Complex formation of human papillomavirus E7 proteins with the retinoblastoma tumor suppressor gene product. EMBO J. 8:4099-4105.
53. Nakagawa, S., and J. M. Huibregtse. 2000. Human scribble (Vartul) is targeted for ubiquitin-mediated degradation by the high-risk papillomavirus E6 proteins and the E6AP ubiquitin-protein ligase. Mol. Cell. Biol. 20:8244-8253.
54. Nees, M., J. M. Geoghegan, T. Hyman, S. Frank, L. Miller, and C. D. Woodworth. 2001. Papillomavirus type 16 oncogenes downregulate expression of interferon-responsive genes and upregulate proliferation-associated and NF-kappaB-responsive genes in cervical keratinocytes. J. Virol. 75:4283-4296.
55. Pereira, S. G., and F. Oakley. 2008. Nuclear factor-kappaB1: regulation and function. Int. J. Biochem. Cell Biol. 40:1425-1430.
56. Perkins, N. D. 2007. Integrating cell-signalling pathways with NF-kappaB and IKK function. Nat. Rev. Mol. Cell Biol. 8:49-62.
57. Perkins, N. D., and T. D. Gilmore. 2006. Good cop, bad cop: the different faces of NF-kappaB. Cell Death Differ. 13:759-772.
58. Qin, J. Z., V. Chaturvedi, M. F. Denning, D. Choubey, M. O. Diaz, and B. J. Nickoloff. 1999. Role of NF-kappaB in the apoptotic-resistant phenotype of keratinocytes. J. Biol. Chem. 274:37957-37964.
59. Scheffner, M., J. M. Huibregtse, R. D. Vierstra, and P. M. Howley. 1993. The HPV-16 E6 and E6-AP complex functions as a ubiquitin-protein ligase in the ubiquitination of p53. Cell 75:495-505.
60. Seitz, C. S., H. Deng, K. Hinata, Q. Lin, and P. A. Khavari. 2000. Nuclear factor kappaB subunits induce epithelial cell growth arrest. Cancer Res. 60:4085-4092.
61. Seitz, C. S., R. A. Freiberg, K. Hinata, and P. A. Khavari. 2000. NF-kappaB determines localization and features of cell death in epidermis. J. Clin. Invest. 105:253-260.
62. Song, Z., S. Krishna, D. Thanos, J. L. Strominger, and S. J. Ono. 1994. A novel cysteine-rich sequence-specific DNA-binding protein interacts with the conserved X-box motif of the human major histocompatibility complex class II genes via a repeated Cys-His domain and functions as a transcriptional repressor. J. Exp. Med. 180:1763-1774.
63. Spitkovsky, D., S. P. Hehner, T. G. Hofmann, A. Moller, and M. L. Schmitz. 2002. The human papillomavirus oncoprotein E7 attenuates NF-kappa B activation by targeting the Ikappa B kinase complex. J. Biol. Chem. 277:25576-25582.
64. Takizawa, S., K. Nagasaka, S. Nakagawa, T. Yano, K. Nakagawa, T. Yasugi, T. Takeuchi, T. Kanda, J. M. Huibregtse, T. Akiyama, and Y. Taketani. 2006. Human scribble, a novel tumor suppressor identified as a target of high-risk HPV E6 for ubiquitin-mediated degradation, interacts with adenomatous polyposis coli. Genes Cells 11:453-464.
65. Ten, R. M., C. V. Paya, N. Israel, O. Le Bail, M. G. Mattei, J. L. Virelizier, P. Kourilsky, and A. Israel. 1992. The characterization of the promoter of the gene encoding the p50 subunit of NF-kappa B indicates that it participates in its own regulation. EMBO J. 11:195-203.
66. Tergaonkar, V., and N. D. Perkins. 2007. p53 and NF-kappaB crosstalk: IKKalpha tips the balance. Mol. Cell 26:158-159.
67. Thomas, J. T., W. G. Hubert, M. N. Ruesch, and L. A. Laimins. 1999. Human papillomavirus type 31 oncoproteins E6 and E7 are required for the maintenance of episomes during the viral life cycle in normal human keratinocytes. Proc. Natl. Acad. Sci. U. S. A. 96:8449-8454.
68. Tommasino, M., and L. Crawford. 1995. Human papillomavirus E6 and E7: proteins which deregulate the cell cycle. Bioessays 17:509-518.
69. Waterfield, M. R., M. Zhang, L. P. Norman, and S. C. Sun. 2003. NF-kappaB1/p105 regulates lipopolysaccharide-stimulated MAP kinase signaling by governing the stability and function of the Tpl2 kinase. Mol. Cell 11:685-694.
70. Wissink, S., A. van de Stolpe, E. Caldenhoven, L. Koenderman, and P. T. van der Saag. 1997. NF-kappa B/Rel family members regulating the ICAM-1 promoter in monocytic THP-1 cells. Immunobiology 198:50-64. (Pubitemid 28021381)
71. Xu, M., W. Luo, D. J. Elzi, C. Grandori, and D. A. Galloway. 2008. NFX1 interacts with mSin3A/histone deacetylase to repress hTERT transcription in keratinocytes. Mol. Cell. Biol. 28:4819-4828.
72. Yuan, H., F. Fu, J. Zhuo, W. Wang, J. Nishitani, D. S. An, I. S. Chen, and X. Liu. 2005. Human papillomavirus type 16 E6 and E7 oncoproteins upregulate c-IAP2 gene expression and confer resistance to apoptosis. Oncogene 24:5069-5078. (Pubitemid 41129084)
73. zur Hausen, H. 1991. Human papillomaviruses in the pathogenesis of anogenital cancer. Virology 184:9-13.
74. zur Hausen, H. 1991. Viruses in human cancers. Science 254:1167-1173.